Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

454 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Acute jaundice in Vientiane, Lao People's Democratic Republic.
Bounlu K, Insisiengmay S, Vanthanouvong K, Saykham, Widjaja S, Iinuma K, Matsubayashi K, Laras K, Putri MP, Endy TP, Vaughn DW, Raengsakulrach B, Hyams KC, Hayden M, Scheffel C, Corwin AL. Bounlu K, et al. Among authors: iinuma k. Clin Infect Dis. 1998 Oct;27(4):717-21. doi: 10.1086/514948. Clin Infect Dis. 1998. PMID: 9798023
Genotypic analysis of hepatitis C virus in blood donors in Indonesia.
Inoue Y, Sulaiman HA, Matsubayashi K, Julitasari, Iinuma K, Ansari A, Laras K, Corwin AL. Inoue Y, et al. Among authors: iinuma k. Am J Trop Med Hyg. 2000 Jan;62(1):92-8. doi: 10.4269/ajtmh.2000.62.92. Am J Trop Med Hyg. 2000. PMID: 10761731
Ten-Year Outcomes of a Phase 3, Multicenter, Randomized Controlled Trial (SHIP0804) With 3-Month Neoadjuvant Androgen Deprivation Prior to 125I-Seed Transperineal Prostate Brachytherapy Followed by Nil Versus 9-Month Adjuvant Hormonal Therapy in Patients With Intermediate-Risk Prostate Cancer.
Fukuokaya W, Miki K, Aoki M, Takahashi H, Saito S, Yorozu A, Kikuchi T, Dokiya T, Egawa S; SHIP Collaborative Group. Fukuokaya W, et al. Int J Radiat Oncol Biol Phys. 2024 Nov 16:S0360-3016(24)03584-3. doi: 10.1016/j.ijrobp.2024.11.010. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 39551103
Oncologic Outcomes of Patients with Immune Checkpoint Inhibitor Resistant Urothelial Carcinoma Treated with Enfortumab Vedotin and the Impact of Neutrophil-to-Lymphocyte Ratio and Dysgeusia on Overall Survival: A Retrospective Multicenter Cohort Study in Japan.
Nakane K, Taniguchi K, Nezasa M, Enomoto T, Yamada T, Tomioka-Inagawa R, Niwa K, Tomioka M, Ishida T, Nagai S, Yokoi S, Taniguchi T, Kawase M, Kawase K, Iinuma K, Tobisawa Y, Koie T. Nakane K, et al. Among authors: iinuma k. Cancers (Basel). 2024 Jul 25;16(15):2648. doi: 10.3390/cancers16152648. Cancers (Basel). 2024. PMID: 39123376 Free PMC article.
454 results